Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Sanofi and Regeneron Diversity, Equity and Inclusion Mid-Career Award

Dermatology Foundation

The Dermatology Foundation and the Skin of Color Society are pleased to introduce this new mid-career award that is intended to support the work of outstanding investigators with an established trajectory of excellence in basic, clinical, or translational science. The supported research projects are expected to yield novel results that expand the understanding of dermatological issues impacting underrepresented or underserved groups in medicine.

Specialties

Clinical Trials

Global Health

Health Policy & Ethics

Dermatology

Health Disparities

Healthcare Delivery

Eligibility Requirements

Proposed project must address an issue impacting groups underrepresented or underserved in medicine
Strong demonstrated commitment to research
At least 75% of their time is committed to research
Appropriate training and experience in relevant research
Faculty appointment in an accredited dermatology department/division, within 12 years of appointment as an Assistant Professor (as of January 1, 2025)
Demonstrates a strong commitment to research in aspects of dermatology
MD; MD, PhD; DO; or PhD degree
Research aims are unique to this award
Cannot hold other DF support at the time of funding (CDA-Yr3 recipients may apply)

Sponsor Details

Sponsor Institute/Organizations: Dermatology Foundation

Address: 1560 Sherman Avenue, Suite 500 Evanston, IL 60201-4806

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity

Award

Letter Of Intent Deadline:

Dec 01, 2024

Final Deadline:

Dec 01, 2024

Funding Amount:

$100,000

3 awards available. The Sanofi-Regeneron Award provides $100,000 in annual support for up to three years. Award funds may be used for any combination of salary and related benefits, and project expenses supporting a meritorious project